Should I Buy VIVS? VIVS 2026 Analysis

Should You Buy VivoSim Labs Inc (VIVS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

2.920

1 Day change

71.76%

52 Week Range

21.960

Analysis Updated At

2026/01/26

VivoSim Labs Inc (VIVS) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is weak, with declining revenue, net income, and EPS. There are no positive trading trends, news catalysts, or significant insider or hedge fund activity. Additionally, technical indicators and trading signals do not suggest a strong entry point, and the stock's projected trend indicates a high likelihood of further declines in the short to medium term.

Technical Analysis

The MACD histogram is positive but contracting, RSI is neutral at 34.038, and moving averages are converging. Key support and resistance levels indicate the stock is trading near its support (S1: 1.92, S2: 1.854), with limited upside potential. The stock has an 80% chance of declining by -5.52% in the next week and -10.54% in the next month.

Options Data

Positive Catalysts

Gross margin increased by 3.44% YoY, reaching 100.

Neutral/Negative Catalysts

Revenue dropped by -6.67% YoY, net income fell by -0.16% YoY, and EPS declined significantly by -42.35% YoY. No recent news, hedge fund activity, or insider trading trends. The stock is projected to decline further in the short to medium term.

Financial Performance

In Q2 2026, revenue dropped to $28,000 (-6.67% YoY), net income fell to -$2,545,000 (-0.16% YoY), and EPS declined to -0.98 (-42.35% YoY). Gross margin increased to 100 (+3.44% YoY), but overall financial performance is weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target changes available.

Analyst Rating

Wall Street analysts forecast VIVS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VIVS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold